June 28, 2010

HemCon Medical Technologies, Inc. introduces the flexible-by-design, HemCon® Patch for use for external, temporary control of bleeding during interventional and diagnostic cardiac catheterization, interventional radiology, electrophysiology and dialysis access procedures. The new patch offers:

• Diagnostic and interventional patients a quick, safe and comfortable post-procedural experience.
• A flexible hemostatic solution where rapid arterial hemostasis is important to ensure quality care and safety.
• The ability to reliably and quickly stops bleeding, minimizes risk of artery damage and frees up medical personnel.
• An FDA antibacterial barrier claim, providing a barrier against a wide spectrum of micro-organisms, including methicillin-resistant Staphylococcus aureus (MRSA), Enterococcus faecalis (VRE) and Acinetobacter baumannii.
• Ability to help to reduce the risk of hospital-acquired infections for both patients and providers.
• Ideal use for patients that take anticoagulant medications or suffer from clotting or bleeding disorders.

For more information, visit www.hemcon.com

---

HemCon Medical Technologies, Inc.
10575 SW Cascade Avenue, Suite 130, Portland, OR 97223-4363.

Email for more information
Company's other products
Email to a colleague
See similar products
Printer friendly format